Last reviewed · How we verify

NCT03457974

Saliva Profiles in Children With Congenital Heart Disease

Completed NA Last updated 8 March 2018
What this trial tests

NA trial testing saliva in Cardiac Disease in 84 participants. Completed in 1 January 2012.

Timeline
1 January 2011
Primary endpoint
1 January 2012
1 January 2012

Quick facts

Lead sponsorIstanbul University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment84
Start date1 January 2011
Primary completion1 January 2012
Estimated completion1 January 2012

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 3 to 12, any sex, with Cardiac Disease or Dental Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to evaluate whether there are relationships between the salivary oxidative stress status of children with CHD directly dental caries including gender, age, salivary flow rate, salivary pH, salivary buffering capacity and drug intake such as angiotensin-converting enzyme (ACE) inhibitors. If such relationships exist, they might be employed to patient caries -prevention treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Saliva profiles in children with congenital heart disease.
    Koruyucu M, Batu S, Bayram M, Uslu E, et al · · 2020 · cited 3× · PMID 32518911 · DOI 10.26650/eor.20200087

Verify or expand the search:

Other trials of saliva

Trials testing the same drug.

Other recruiting trials for Cardiac Disease

Currently open trials in the same condition.

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03457974.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing